𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma

✍ Scribed by Wolfgang A. Schulz; Jussi P. Elo; Andrea R. Florl; Sari Pennanen; Simon Santourlidis; Rainer Engers; Martin Buchardt; Hans-Helge Seifert; Tapio Visakorpi


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
94 KB
Volume
35
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To elucidate the relationship between genomewide DNA hypomethylation and chromosome instability, 55 prostate carcinoma specimens were analyzed for extent of hypomethylation by Southern blot analysis of LINE‐1 sequence methylation and for loss or gain of chromosomal material by comparative genomic hybridization. Seventeen (31%) tumors showed strong hypomethylation of DNA, whereas four (7%) displayed slight hypomethylation and the rest of the tumors normal‐level methylation. Chromosomal aberrations were observed in 34 carcinomas. The most frequent chromosomal alterations were loss of 13q in 18 cases and aberrations in 8p (loss) or 8q (gain) in 16 cases. The presence of chromosomal loss or gain was significantly associated with the presence of strong hypomethylation. A striking correlation (P = 0.00001) was observed between aberrations on chromosome 8 and hypomethylation, whereas no association was seen between DNA hypomethylation and loss of 13q. The association between DNA hypomethylation and the presence of metastases was statistically significant (P = 0.044), and both chromosomal alterations and DNA hypomethylation tended to be more frequent in higher‐stage tumors. In conclusion, the data indicate that hypomethylation is associated with chromosomal instability in prostate cancer. Specifically, a surprisingly strong association between alterations on chromosome 8 and genomewide hypomethylation was found. This association suggests that DNA hypomethylation and alterations in chromosome 8 may be mechanistically linked to each other in prostate carcinoma. Β© 2002 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Frequent loss Xq25 on the inactive X chr
✍ Zhe Piao; Sergei R. Malkhosyan πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 1 views

## Abstract We previously applied arbitrarily primed polymerase chain reaction DNA fingerprinting to identify molecular genetic alterations in primary breast carcinomas. One of the most frequently observed fingerprint alterations was a reduction in the intensity of the MCG1‐B2 band in 32% of tumors

A widely expressed transcription factor
✍ Galina N. Filippova; Annika Lindblom; Linda J. Meincke; Elena M. Klenova; Paul E πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

The cellular protooncogene MYC encodes a nuclear transcription factor that is involved in regulating important cellular functions, including cell cycle progression, differentiation, and apoptosis. Dysregulated MYC expression appears critical to the development of various types of malignancies, and t